MeiraGTx (MGTX) Stock Forecast, Price Target & Predictions
MGTX Stock Forecast
MeiraGTx stock forecast is as follows: an average price target of $9.00 (represents a 111.76% upside from MGTX’s last price of $4.25) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
MGTX Price Target
MGTX Analyst Ratings
MeiraGTx Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 13, 2024 | Luca Issi | RBC Capital | $9.00 | $4.02 | 123.88% | 111.76% |
MeiraGTx Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 1 |
Avg Price Target | - | $9.00 | $9.00 |
Last Closing Price | $4.25 | $4.25 | $4.25 |
Upside/Downside | -100.00% | 111.76% | 111.76% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 13, 2024 | RBC Capital | Outperform | Outperform | Hold |
MeiraGTx Financial Forecast
MeiraGTx Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $2.04M | $5.10M | - | $3.33M | $-5.29M | $4.82M | - | $5.63M | $4.38M | $6.95M | $5.12M | $4.59M | $3.79M | $5.09M | $2.47M | $4.21M | $3.58M | $1.98M | $784.96K |
Avg Forecast | $187.21M | $16.98M | $14.17M | $9.95M | $1.63M | $1.63M | $9.70M | $9.70M | $6.56M | $3.27M | $4.17M | $4.87M | $10.90M | $6.99M | $5.82M | $4.08M | $2.40M | $2.25M | $1.43M | $5.68M | $907.02K | $2.70M | $1.65M | $700.00K | $863.46K | $2.50K | $810.28K |
High Forecast | $346.68M | $31.45M | $26.24M | $18.42M | $3.01M | $3.01M | $17.96M | $17.96M | $12.15M | $6.06M | $7.72M | $9.01M | $20.19M | $12.95M | $5.82M | $5.13M | $3.01M | $2.83M | $1.80M | $7.13M | $1.14M | $3.39M | $1.98M | $879.36K | $1.08M | $3.14K | $972.34K |
Low Forecast | $28.89M | $2.62M | $2.19M | $1.53M | $250.77K | $250.77K | $1.50M | $1.50M | $1.01M | $504.63K | $643.05K | $750.77K | $1.68M | $1.08M | $5.82M | $3.03M | $1.78M | $1.67M | $1.07M | $4.22M | $674.27K | $2.01M | $1.32M | $520.37K | $641.88K | $1.86K | $648.22K |
# Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 10 | 10 | 15 | 10 | 4 | 4 | 10 |
Surprise % | - | - | - | - | - | - | - | - | 0.31% | 1.56% | - | 0.69% | -0.49% | 0.69% | - | 1.38% | 1.83% | 3.09% | 3.57% | 0.81% | 4.18% | 1.89% | 1.50% | 6.01% | 4.15% | 792.67% | 0.97% |
MeiraGTx EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 10 | 10 | 15 | 10 | 4 | 4 | 10 |
EBITDA | - | - | - | - | - | - | - | - | $-43.75M | $-28.76M | $-28.79M | $-31.16M | $-37.77M | $-20.49M | - | $-26.60M | $-10.37M | $-23.85M | $-18.02M | $-21.80M | $1.38M | $-5.33M | $-24.44M | $-14.83M | $-10.26M | $-20.37M | $-17.47M |
Avg Forecast | $-187.21M | $-16.98M | $-14.17M | $-9.95M | $-1.63M | $-1.63M | $-9.70M | $-9.70M | $-6.56M | $-3.27M | $-4.17M | $-4.87M | $-10.90M | $-19.30M | $-5.82M | $-18.86M | $-2.40M | $-20.64M | $-20.40M | $-15.57M | $-907.02K | $-8.43M | $-13.44M | $-16.38M | $-13.14M | $-35.52M | $-18.02M |
High Forecast | $-28.89M | $-2.62M | $-2.19M | $-1.53M | $-250.77K | $-250.77K | $-1.50M | $-1.50M | $-1.01M | $-504.63K | $-643.05K | $-750.77K | $-1.68M | $-15.44M | $-5.82M | $-15.09M | $-1.78M | $-16.51M | $-16.32M | $-12.46M | $-674.27K | $-6.75M | $-10.76M | $-13.10M | $-10.51M | $-28.41M | $-14.41M |
Low Forecast | $-346.68M | $-31.45M | $-26.24M | $-18.42M | $-3.01M | $-3.01M | $-17.96M | $-17.96M | $-12.15M | $-6.06M | $-7.72M | $-9.01M | $-20.19M | $-23.16M | $-5.82M | $-22.64M | $-3.01M | $-24.77M | $-24.48M | $-18.69M | $-1.14M | $-10.12M | $-16.13M | $-19.65M | $-15.76M | $-42.62M | $-21.62M |
Surprise % | - | - | - | - | - | - | - | - | 6.67% | 8.80% | 6.91% | 6.41% | 3.46% | 1.06% | - | 1.41% | 4.32% | 1.16% | 0.88% | 1.40% | -1.52% | 0.63% | 1.82% | 0.91% | 0.78% | 0.57% | 0.97% |
MeiraGTx Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 10 | 10 | 15 | 10 | 4 | 4 | 10 |
Net Income | - | - | - | - | - | - | - | - | $20.21M | $-44.30M | $-29.58M | $-32.03M | $-13.57M | $-51.76M | - | $-33.36M | $-12.16M | $-25.95M | $-20.09M | $-23.62M | $-10.46K | $-6.43M | $-25.42M | $-15.68M | $-10.46M | $-20.82M | $-17.98M |
Avg Forecast | $75.96M | $16.74M | $12.55M | $9.98M | $-34.76M | $-33.80M | $-25.75M | $-32.51M | $1.61M | $-35.19M | $-35.25M | $-42.27M | $-37.45M | $-20.99M | $-41.00M | $-20.30M | $-32.18M | $-22.45M | $-22.74M | $-16.87M | $-44.27M | $-10.17M | $-13.98M | $-17.31M | $-13.40M | $-36.31M | $-18.54M |
High Forecast | $160.09M | $35.27M | $26.45M | $21.03M | $3.45M | $3.36M | $2.56M | $3.23M | $3.39M | $3.50M | $3.50M | $4.20M | $3.72M | $-16.79M | $-41.00M | $-16.24M | $-21.45M | $-17.96M | $-18.19M | $-13.50M | $-29.50M | $-8.14M | $-11.18M | $-13.85M | $-10.72M | $-29.05M | $-14.84M |
Low Forecast | $-7.55M | $-1.66M | $-1.25M | $-991.67K | $-73.26M | $-71.23M | $-54.27M | $-68.51M | $-159.95K | $-74.17M | $-74.28M | $-89.09M | $-78.91M | $-25.19M | $-41.00M | $-24.36M | $-42.90M | $-26.94M | $-27.29M | $-20.24M | $-59.01M | $-12.21M | $-16.78M | $-20.78M | $-16.08M | $-43.57M | $-22.25M |
Surprise % | - | - | - | - | - | - | - | - | 12.56% | 1.26% | 0.84% | 0.76% | 0.36% | 2.47% | - | 1.64% | 0.38% | 1.16% | 0.88% | 1.40% | 0.00% | 0.63% | 1.82% | 0.91% | 0.78% | 0.57% | 0.97% |
MeiraGTx SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 10 | 10 | 15 | 10 | 4 | 4 | 10 |
SG&A | - | - | - | - | - | - | - | - | $12.12M | $10.01M | $12.39M | $12.77M | $14.00M | $10.76M | - | $11.27M | $15.55M | $7.89M | $10.41M | $9.92M | $12.01M | $8.90M | $11.50M | $11.81M | $9.87M | $13.44M | $8.50M |
Avg Forecast | $481.25M | $43.66M | $36.43M | $25.57M | $4.18M | $4.18M | $24.94M | $24.94M | $16.87M | $8.41M | $10.71M | $12.51M | $28.03M | $6.38M | $14.95M | $10.49M | $6.17M | $5.78M | $3.68M | $14.59M | $2.33M | $6.94M | $4.24M | $1.80M | $2.22M | $6.43K | $2.08M |
High Forecast | $891.21M | $80.86M | $67.45M | $47.35M | $7.74M | $7.74M | $46.18M | $46.18M | $31.24M | $15.57M | $19.84M | $23.16M | $51.90M | $7.66M | $14.95M | $13.18M | $7.75M | $7.27M | $4.63M | $18.33M | $2.93M | $8.72M | $5.09M | $2.26M | $2.79M | $8.07K | $2.50M |
Low Forecast | $74.27M | $6.74M | $5.62M | $3.95M | $644.65K | $644.65K | $3.85M | $3.85M | $2.60M | $1.30M | $1.65M | $1.93M | $4.33M | $5.11M | $14.95M | $7.80M | $4.59M | $4.30M | $2.74M | $10.85M | $1.73M | $5.16M | $3.39M | $1.34M | $1.65M | $4.78K | $1.67M |
Surprise % | - | - | - | - | - | - | - | - | 0.72% | 1.19% | 1.16% | 1.02% | 0.50% | 1.69% | - | 1.07% | 2.52% | 1.36% | 2.82% | 0.68% | 5.15% | 1.28% | 2.71% | 6.56% | 4.45% | 2091.06% | 4.08% |
MeiraGTx EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | 10 | 10 | 15 | 10 | 4 | 4 | 10 |
EPS | - | - | - | - | - | - | - | - | $0.42 | $-0.74 | $-0.00 | $-0.66 | $-0.31 | $-1.16 | - | $-0.75 | $-0.28 | $-0.59 | $-0.46 | $-0.54 | $-0.00 | $-0.17 | $-0.69 | $-0.43 | $-0.30 | $-0.63 | $-0.62 |
Avg Forecast | $1.18 | $0.26 | $0.20 | $0.15 | $-0.54 | $-0.53 | $-0.40 | $-0.51 | $0.03 | $-0.55 | $-0.55 | $-0.66 | $-0.58 | $-0.64 | $-0.64 | $-0.49 | $-0.51 | $-0.54 | $-0.40 | $-0.30 | $-0.70 | $-0.46 | $-0.48 | $-0.52 | $-0.16 | $-0.64 | $-0.66 |
High Forecast | $2.49 | $0.55 | $0.41 | $0.33 | $0.05 | $0.05 | $0.04 | $0.05 | $0.05 | $0.05 | $0.05 | $0.07 | $0.06 | $0.06 | $-0.64 | $-0.33 | $-0.34 | $-0.36 | $-0.27 | $-0.20 | $-0.46 | $-0.31 | $-0.32 | $-0.34 | $-0.11 | $-0.43 | $-0.53 |
Low Forecast | $-0.12 | $-0.03 | $-0.02 | $-0.02 | $-1.14 | $-1.11 | $-0.84 | $-1.06 | $-0.00 | $-1.15 | $-1.15 | $-1.38 | $-1.23 | $-1.35 | $-0.64 | $-0.66 | $-0.67 | $-0.72 | $-0.53 | $-0.40 | $-0.93 | $-0.61 | $-0.64 | $-0.69 | $-0.21 | $-0.85 | $-0.79 |
Surprise % | - | - | - | - | - | - | - | - | 16.80% | 1.35% | 0.00% | 1.01% | 0.53% | 1.81% | - | 1.52% | 0.55% | 1.10% | 1.15% | 1.82% | 0.00% | 0.37% | 1.43% | 0.83% | 1.88% | 0.98% | 0.94% |
MeiraGTx Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
QURE | uniQure | $5.66 | $53.67 | 848.23% | Buy |
KRON | Kronos Bio | $0.95 | $7.63 | 703.16% | Buy |
FIXX | Q32 Bio | $0.93 | $2.70 | 190.32% | Buy |
ABOS | Acumen Pharmaceuticals | $2.60 | $7.00 | 169.23% | Buy |
EWTX | Edgewise Therapeutics | $18.83 | $48.00 | 154.91% | Buy |
RCKT | Rocket Pharmaceuticals | $19.65 | $47.33 | 140.87% | Buy |
ERAS | Erasca | $2.97 | $7.00 | 135.69% | Buy |
NUVB | Nuvation Bio | $3.05 | $7.00 | 129.51% | Buy |
SLDB | Solid Biosciences | $7.93 | $17.50 | 120.68% | Buy |
MGTX | MeiraGTx | $4.25 | $9.00 | 111.76% | Buy |
KROS | Keros Therapeutics | $56.98 | $105.00 | 84.28% | Buy |
CCCC | C4 Therapeutics | $6.44 | $11.33 | 75.93% | Hold |
ETON | Eton Pharmaceuticals | $5.15 | $8.50 | 65.05% | Buy |
IDYA | IDEAYA Biosciences | $37.46 | $46.13 | 23.14% | Buy |
CNTB | Connect Biopharma | $1.23 | $1.50 | 21.95% | Buy |
ANAB | AnaptysBio | $40.33 | $36.33 | -9.92% | Buy |
RYTM | Rhythm Pharmaceuticals | $49.62 | $38.33 | -22.75% | Buy |
MGTX Forecast FAQ
Is MeiraGTx a good buy?
Yes, according to 1 Wall Street analysts, MeiraGTx (MGTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of MGTX's total ratings.
What is MGTX's price target?
MeiraGTx (MGTX) average price target is $9 with a range of $9 to $9, implying a 111.76% from its last price of $4.25. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will MeiraGTx stock go up soon?
According to Wall Street analysts' prediction for MGTX stock, the company can go up by 111.76% (from the last price of $4.25 to the average price target of $9), up by 111.76% based on the highest stock price target, and up by 111.76% based on the lowest stock price target.
Can MeiraGTx stock reach $6?
MGTX's average twelve months analyst stock price target of $9 supports the claim that MeiraGTx can reach $6 in the near future.
What are MeiraGTx's analysts' financial forecasts?
MeiraGTx's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $22.65M (high $41.94M, low $3.5M), average EBITDA is $-22.65M (high $-3.495M, low $-41.944M), average net income is $-127M (high $12.6M, low $-267M), average SG&A $58.23M (high $107.83M, low $8.99M), and average EPS is $-1.97 (high $0.196, low $-4.152). MGTX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $228.31M (high $422.79M, low $35.23M), average EBITDA is $-228M (high $-35.233M, low $-423M), average net income is $115.23M (high $242.84M, low $-11.452M), average SG&A $586.91M (high $1.09B, low $90.57M), and average EPS is $1.79 (high $3.77, low $-0.178).
Did the MGTX's actual financial results beat the analysts' financial forecasts?
Based on MeiraGTx's last annual report (Dec 2022), the company's revenue was $15.92M, which missed the average analysts forecast of $27.8M by -42.73%. Apple's EBITDA was $-116M, beating the average prediction of $-54.88M by 110.60%. The company's net income was $-143M, beating the average estimation of $-120M by 19.32%. Apple's SG&A was $46.55M, missing the average forecast of $59.86M by -22.23%. Lastly, the company's EPS was $-3.16, beating the average prediction of $-2.357 by 34.09%. In terms of the last quarterly report (Dec 2023), MeiraGTx's revenue was $2.04M, missing the average analysts' forecast of $6.56M by -68.91%. The company's EBITDA was $-43.754M, beating the average prediction of $-6.562M by 566.73%. MeiraGTx's net income was $20.22M, beating the average estimation of $1.61M by 1156.05%. The company's SG&A was $12.12M, missing the average forecast of $16.87M by -28.13%. Lastly, the company's EPS was $0.42, beating the average prediction of $0.025 by 1580.00%